Metastatic Trial Talk (MTT) was created to address the overwhelming amount of breast cancer information available online. We carefully select news and features about metastatic breast cancer research to help patients when making treatment decisions, including whether to enter a clinical trial.
MTT was developed by BreastCancerTrials.org as a companion to Metastatic Trial Search, a clinical trial matching tool designed specifically for people with metastatic breast cancer.
Kristine De La Torre, PhD - Content Editor
Kris is the MTT Editor for Metastatic Trial Talk and thus, selects the content for each month’s MTT. As a freelance medical writer, her interests are in facilitating bidirectional communication between patients and the medical community. She holds a PhD in neurobiology from the University of North Carolina at Chapel Hill.
Alexandra Burd, MMB - Managing Editor
Leeza Patel, MBA - Technical Editor
Leeza is the Data Scientist with BreastCancerTrials.org. She has a Bachelors in Computer Engineering and dual MBA in Healthcare Management and Enterprise Resource Planning from Scranton University. She has 8 years of experience in the healthcare field and is passionate about using data to drive change in people’s lives using data science and analytics. Her interest in healthcare stems from her passion to impact and improve quality of life for more diverse populations.
Susan Colen — Program Director
Susan Colen is the Program Director of BreastCancerTrials.org (BCT). She has been involved with BCT since just after its nationwide launch in 2008 and has contributed to the development of Metastatic Trial Search, Metastatic Trial Talk, and CTMatch, BCT’s innovative trial matching platform. Her interest, passion, and experience is in breast cancer advocacy and clinical trial education. Having lost her mother to breast cancer when she was five years old, she is committed to the mission of advancing research and eradicating breast cancer. Susan has a B.S. in Industrial Engineering and Operations Research, is a graduate of the UC Berkeley Extension’s Clinical Research Conduct and Management program (2009) and NBCC Project LEAD (2015) and is a member of the Metastatic Breast Cancer Alliance.
Elly Cohen, PhD — Co-Founder and Senior Advisor
Elly was the Program Director of BreastCancerTrials.org (BCT) from its beginning as a UCSF-NCI research pilot through 2020, developing BCT into a highly regarded nationwide, non-profit service. Under her leadership, BCT grew into a family of applications that include BCT Match, BCT Browse, Metastatic Trial Search, and Metastatic Trial Talk. Elly is an active contributor as Senior Advisor at Quantum Leap Healthcare Collaborative, the sponsor of BCT. She is frequently invited to talk about clinical trials to patient groups and is actively involved in the Metastatic Breast Cancer Alliance. Elly has a Ph.D. in Pathology from Cornell University and is a breast cancer survivor.
BreastCancerTrials.org (BCT) is a patient-friendly, online clinical trial matching service focused exclusively on breast cancer. It maintains a registry of over 500 studies actively recruiting patients in the USA, including clinical trials and observational studies. Conceived by patients, and developed at the UCSF Carol Franc Buck Breast Care Center, BCT was validated in a UCSF/NCI research pilot prior to its nationwide launch in 2008. The mission of BCT is to accelerate breast cancer research by making patient consideration of trials the norm vs. the exception. Towards that goal, BCT develops tools and services that engage patients to discuss trials with their providers as a routine option for care.
BCT is a program of Quantum Leap Health Care Collaborative, a non-profit organization affiliated with the UCSF Carol Franc Buck Breast Care Center.
For more information, visit BreastCancerTrials.org.
About Metastatic Trial Search
Metastatic Trial Search (MTS) is a clinical trial search tool designed specifically for patients with metastatic breast cancer. Launched in 2015, MTS was developed by BreastCancerTrials.org in collaboration with the following breast cancer advocacy organizations:
MTS is embedded on the websites of many partner sites providing patients with easy access to trial information from within their trusted communities. MTS is currently available on these sites:
- After Breast Cancer Diagnosis
- Angelmira’s Center for Women with Advanced Cancer
- Association of Community Cancer Centers
- Breast Cancer Care & Research Fund
- Cancer Support Community
- Diverse Health Hub
- Dr. Susan Love Research Foundation
- For the Breast of Us
- Hope Scarves
- Inflammatory Breast Cancer Research Foundation
- Learn Look Locate
- Living Beyond Breast Cancer
- Lobular Breast Cancer Alliance (LBCA)
- A Male Breast Cancer Blog
- Male Breast Cancer Happens
- Male Breast Cancer Global Alliance
- MET UP
- MBC Alliance
- Metastatic Breast Cancer Network
- Metastatic Breast Cancer Project
- National Breast Cancer Foundation
- Patient Advocate Foundation
- Research Match
- SHARE Cancer Support
- Storm Riders Network
- Story Half Told
- Susan G. Komen
- Theresa’s Research Foundation
- Tigerlily Foundation
- The Second Opinion
- Triple Negative Breast Cancer Foundation
- Triage Cancer
- Twisted Pink
- When We Tri(al)
- Young Survival Coalition
For more information, visit Metastatic Trial Search.
About Quantum Leap Healthcare Collaborative
A 501C(3) charitable organization, Quantum Leap Healthcare Collaborative (QLHC) was established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. Their mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved data management and information systems, greater access to clinical trial matching and sponsorship, and greater benefit to providers, patients and researchers – to improve and save lives. QLHC’s portfolio includes BCT, CTMatch, I-SPY trials, and OneSource.
For more information, visit Quantum Leap Healthcare Collaborative
SEARCH OUR SITE
for past articles or specific information.